Evonik, a leading global system solutions provider, and BellaSeno, a developer of 3D-printed absorbable scaffolds, are working together to commercialize 3D-printed scaffolds for bone regeneration.
 
The bone scaffolds are made with Evonik’s Resomer polymers and are used for large and complex bone defects. Both companies initially began collaborating in 2019 on scaffolds for chest wall and breast reconstruction.
 
“We are excited that these scaffolds offer patients superior healing for bone defects. In BellaSeno we have found a likeminded partner, passionate to innovate for better health and well-being,” said Andreas Karau, global head of Medical Device Solutions at Evonik’s Health Care business line.
 
BellaSeno’s custom-made, resorbable bone scaffolds bring a step-change in the way bone and soft tissue defects are treated by ensuring the correct anatomical positions of tissue grafts. Although tissue autographs are considered the gold standard for tissue regeneration, they sometimes lack stability and cannot be packed in a controlled manner. BellaSeno’s 3D-printed tissue scaffolds address these limitations.
 
Resomer is a comprehensive GMP (Good Manufacturing Practice) portfolio of standard, custom and specialized bioresorbable polymers for use with implantable medical devices. Various special Resomer formulations for 3D printing include filaments and powders to enable customized solutions for a diverse range of applications.
 
“Evonik’s Resomer polymers combine excellent stability and flexibility. These mechanical properties and their degradation profile allow the scaffold to be safely absorbed at a rate that matches the formation of the patient’s own bone,” said Mohit Chhaya, CEO of BellaSeno. “We believe that these novel bone generation implants hold great promise for patients.”